NiceOne Beauty Digital Marketing Co. announces the results of Extraordinary General Assembly meeting. (First meeting) to its shareholders.

1. Mr. Amr Abdulaziz Al-Jallal (Board Chairman)

2. Mr. Abdulrahman Ali Al-Olayan (Vice Chairman)

3. Prince Mansour Saad Mohammed Al-Saud

4. Mr. Mohamed Ahmed Loughzail

5. Mr. Omar Ali Al-Olayan

6. Mr. Abdulaziz Mohammad Al-Rugaib

7. Mr. Ibrahem Abdulrahman Al-Suhaibani

2. Prince Mansour Saad Mohammed Al-Saud (The Chairman of Audit Committee)

3. Mr. Mohamed Ahmed Loughzail (The Chairman of Nomination and Remuneration Committee)

2. Reviewing and discussing the Financial Statements for the fiscal year ended 31st December 2024.

3. Approval of the company's auditor's report for the fiscal year ended 31st December 2024, after discussing it.

4. Approved the appointment of Ernst & Young (EY) as an independent auditor for the company’s accounts from among the candidates based on the recommendation of the Audit Committee, in order to examine, review and audit preliminary financial statements for the second and third quarters, and the annual financial statements for the fiscal year 2025, and the first quarter of 2026, with audit fees of 1,431,750 SAR.

5. Approved the delegating of the authority of the General Assembly to the Board of Directors with the authorization contained in Paragraph (1) of Article Twenty-Seven (27) of the Companies Law, for a period of one year from the date of the General Assembly’s approval or until the end of the session of the delegated Board of Directors, whichever comes first, in accordance with the conditions stated in the executive regulations. The corporate system for listed joint stock companies.

6. Approved the disbursement of an amount of (1,773,836) SR as a reward to members of the Board of Directors for the fiscal year ending on December 31, 2024.

7. Approved the participation of the Board Chairman, Mr. Amr Abdulaziz Abdullah Al-Jallal, in an activity that competes with the company's business, through his membership on the Board of Directors of International Healthcare Company (Whites and Kunooz Pharmacies).

8. Approved the Board of Directors’ recommendation to transfer an amount of SAR 318,900 from the company’s statutory reserve to the retained earnings balance, as reflected in the financial statements for the year ended 31/12/2024.

9. Approved the release of the Board of Directors members from liability for the fiscal year ended 31 December 2024.

10. Approved amending Article No. (1) of the company’s bylaws, related to (Incorporation).

11. Approved amending Article No. (2) of the company’s bylaws, related to (Name of the Company).

12. Approved amending Article No. (4) of the company’s bylaws, related to (Objectives of the Company).

13. Approved amending Article No. (8) of the company’s bylaws, related to (Shareholders' Register).

14. Approved amending Article No. (9) of the company’s bylaws, related to (Trading in Shares).

15. Approved amending Article No. (11) of the company’s bylaws, related to (Sale of Non-Paid Shares).

16. Approved amending Article No. (18) of the company’s bylaws, related to (Company’s Management).

17. Approved amending Article No. (31) of the company’s bylaws, related to (Calling for the Convening of General Assemblies).

18. Approved the addition of a new Article No. (20) to the company’s bylaws regarding 'Board Members’ Obligations'.

19. Approved the addition of a new Article No. (43) to the company’s bylaws regarding 'Auditor’s Obligations'.